Kai Liu
About Kai Liu
Kai Liu is a Senior Director of Research at Travere Therapeutics, where he has worked since 2019. He has extensive experience in bioanalysis and drug metabolism, having held key roles at several pharmaceutical companies, including Pfizer and Regulus Therapeutics.
Current Role at Travere Therapeutics
Kai Liu serves as the Senior Director of Research at Travere Therapeutics, a position he has held since 2019. In this role, he plays a key part in strategic planning and execution of clinical pharmacology studies. His responsibilities include overseeing bioanalyses that support both clinical and nonclinical studies. Liu also leads biomarker analyses to support clinical endpoint evaluation and regulatory interactions, contributing significantly to nonclinical and translational development efforts within the organization.
Previous Experience at Travere Therapeutics
Prior to his current role, Kai Liu worked at Travere Therapeutics as the Director of Bioanalysis and DMPK from 2017 to 2019. During this time, he was involved in various aspects of drug development, focusing on bioanalytical methods and drug metabolism and pharmacokinetics. His experience at Travere has been instrumental in shaping the company's research strategies.
Professional Background in Pharmaceutical Science
Kai Liu has extensive experience in the pharmaceutical industry. He worked at Pfizer as a Principal Scientist from 2001 to 2005, contributing to drug development initiatives. He also held positions at Regulus Therapeutics as Director of Bioanalysis and DMPK from 2011 to 2017, and at Metabasis Therapeutics as a Senior Scientific Investigator from 2007 to 2009. Additionally, he served as a Lead Scientist at Ambrx from 2009 to 2010.
Education and Academic Qualifications
Kai Liu has a robust educational background in chemistry and biophysical chemistry. He earned his Ph.D. in Chemistry/Biophysical Chemistry from Columbia University from 1991 to 1996. He completed postdoctoral studies in Biophysical Chemistry at the University of California, Berkeley from 1996 to 2000, and at Scripps Research from 2000 to 2001. He also holds a Bachelor of Science degree in Chemistry from Peking University, which he obtained from 1987 to 1991.
Research Publications and Contributions
Kai Liu has published work in the journal CPT-PSP, with a focus on PBPK modeling. His research contributions are significant in the field of clinical pharmacology, particularly in the areas of biomarker analysis and drug development. His expertise supports both clinical and nonclinical studies, enhancing the understanding of pharmacokinetics and drug interactions.